ulk1 Search Results


86
Jackson Laboratory ulk1
( A ) Schematic illustration of the inducible and conditional <t>Ulk1</t> knockout mouse MPN model used, and analyses performed. (BMT – bone marrow transplant) ( B ) Hemoglobin (Hb) levels, ( C ) hematocrit (HCT) percentage and ( D ) red blood cell (RBC) counts in peripheral blood of Ulk1 +/+ Jak2 V617F and Ulk1 FL/FL Jak2 V617F recipient mice are shown for pre- (day 21) and post- (day 42) pIpC injection. ( E ) Spleen weight and ( F ) percentage of GFP + splenocytes three weeks post pIpC injection of the recipient mice. ( G ) Percentage of GFP + ( G-i ) Ter119 med CD71 high proerythroblasts (R1), ( G-ii ) Ter119 high CD71 high basophilic erythroblasts (R2), and ( G-iii ) Ter119 high CD71 med late basophilic and polychromatophilic erythroblasts (R3) and Ter119 high CD71 low orthochromatophilic erythroblasts (R4) in the spleen of recipient mice three weeks post pIpC injection. ( H ) Percentage of GFP + bone marrow (BM) cells three weeks post pIpC injection of the recipient mice. Percentage of GFP + ( I-i ) R1, ( I-ii ) R2, and ( I-iii ) R3+R4 cells in the BM of recipient mice three weeks post pIpC injection. ( B-I ) Box plots show distribution of data from 6 mice per group. ( B-D ) Mixed effects models were used to analyze these data, with Hb, HCT or RBC counts as the outcome variable, and time (pre- and post-pIpC), genotype and their interaction as fixed effects, and a mouse random effect to account for within-mouse correlation between repeated measurements. Fisher’s LSD approach was used, and pairwise comparison p -values were not adjusted. ( E-I ) Statistical analyses were performed using Mann-Whitney test. ( B-I ) Statistically significant p -values are reported. ns - not significant. See also supplemental figures 1 – 3 .
Ulk1, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ulk1/ulk1/pmc12645588-294-13-17
Average 86 stars, based on 1 article reviews
ulk1 - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

90
OriGene ulk1
( A ) Schematic illustration of the inducible and conditional <t>Ulk1</t> knockout mouse MPN model used, and analyses performed. (BMT – bone marrow transplant) ( B ) Hemoglobin (Hb) levels, ( C ) hematocrit (HCT) percentage and ( D ) red blood cell (RBC) counts in peripheral blood of Ulk1 +/+ Jak2 V617F and Ulk1 FL/FL Jak2 V617F recipient mice are shown for pre- (day 21) and post- (day 42) pIpC injection. ( E ) Spleen weight and ( F ) percentage of GFP + splenocytes three weeks post pIpC injection of the recipient mice. ( G ) Percentage of GFP + ( G-i ) Ter119 med CD71 high proerythroblasts (R1), ( G-ii ) Ter119 high CD71 high basophilic erythroblasts (R2), and ( G-iii ) Ter119 high CD71 med late basophilic and polychromatophilic erythroblasts (R3) and Ter119 high CD71 low orthochromatophilic erythroblasts (R4) in the spleen of recipient mice three weeks post pIpC injection. ( H ) Percentage of GFP + bone marrow (BM) cells three weeks post pIpC injection of the recipient mice. Percentage of GFP + ( I-i ) R1, ( I-ii ) R2, and ( I-iii ) R3+R4 cells in the BM of recipient mice three weeks post pIpC injection. ( B-I ) Box plots show distribution of data from 6 mice per group. ( B-D ) Mixed effects models were used to analyze these data, with Hb, HCT or RBC counts as the outcome variable, and time (pre- and post-pIpC), genotype and their interaction as fixed effects, and a mouse random effect to account for within-mouse correlation between repeated measurements. Fisher’s LSD approach was used, and pairwise comparison p -values were not adjusted. ( E-I ) Statistical analyses were performed using Mann-Whitney test. ( B-I ) Statistically significant p -values are reported. ns - not significant. See also supplemental figures 1 – 3 .
Ulk1, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ulk1/ULK1+Human+shRNA+Plasmid+Kit/pmc03646859-158-11-14
Average 90 stars, based on 1 article reviews
ulk1 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Addgene inc pmxs ip egfp ulk2
(A) Cross-sections of quadriceps from control <t>(Ulk1+/−Ulk2−/flox)</t> and Ulk1/2 hypomorph (Ulk1−/− Ulk2−/flox) mice at 24 weeks were stained with H&E and modified Gomori trichrome staining. Arrow indicates a crescentic inclusion and arrowhead indicates a vacuole. Scale bars, 25 μm.
Pmxs Ip Egfp Ulk2, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ulk1/pMXs-IP-EGFP-ULK1+(Plasmid+%2338193)/pmc06859904-923-4-9
Average 90 stars, based on 1 article reviews
pmxs ip egfp ulk2 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc phospho ulk1
(A) Cross-sections of quadriceps from control <t>(Ulk1+/−Ulk2−/flox)</t> and Ulk1/2 hypomorph (Ulk1−/− Ulk2−/flox) mice at 24 weeks were stained with H&E and modified Gomori trichrome staining. Arrow indicates a crescentic inclusion and arrowhead indicates a vacuole. Scale bars, 25 μm.
Phospho Ulk1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ulk1/ULK1+Rabbit+mAb/pm26212320-186-24-36
Average 96 stars, based on 1 article reviews
phospho ulk1 - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

94
Cell Signaling Technology Inc rabbit anti phospho ulk1 ser757 cell signaling
(A) Cross-sections of quadriceps from control <t>(Ulk1+/−Ulk2−/flox)</t> and Ulk1/2 hypomorph (Ulk1−/− Ulk2−/flox) mice at 24 weeks were stained with H&E and modified Gomori trichrome staining. Arrow indicates a crescentic inclusion and arrowhead indicates a vacuole. Scale bars, 25 μm.
Rabbit Anti Phospho Ulk1 Ser757 Cell Signaling, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ulk1/ULK1+Rabbit+mAb/pm29232555-326-78-81
Average 94 stars, based on 1 article reviews
rabbit anti phospho ulk1 ser757 cell signaling - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

93
Cell Signaling Technology Inc rabbit anti ulk1
(A) Cross-sections of quadriceps from control <t>(Ulk1+/−Ulk2−/flox)</t> and Ulk1/2 hypomorph (Ulk1−/− Ulk2−/flox) mice at 24 weeks were stained with H&E and modified Gomori trichrome staining. Arrow indicates a crescentic inclusion and arrowhead indicates a vacuole. Scale bars, 25 μm.
Rabbit Anti Ulk1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ulk1/ULK1+(R600)+Antibody/pm24494600-69-114-117
Average 93 stars, based on 1 article reviews
rabbit anti ulk1 - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

94
Cell Signaling Technology Inc sampler kit 8359t
KEY RESOURCES TABLE
Sampler Kit 8359t, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ulk1/ULK1+Antibody+Sampler+Kit/pmc06689410-10-5-2
Average 94 stars, based on 1 article reviews
sampler kit 8359t - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc pser757 ulk1
KEY RESOURCES TABLE
Pser757 Ulk1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ulk1/Phospho-ULK1+(Ser757)+Rabbit+mAb/pm37907591-89-102-104
Average 96 stars, based on 1 article reviews
pser757 ulk1 - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc phospho ulk1 ser317
KEY RESOURCES TABLE
Phospho Ulk1 Ser317, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ulk1/Phospho-ULK1+(Ser317)+Antibody/bio_rxiv__64898__2026__01__23__701232-68-31-34
Average 95 stars, based on 1 article reviews
phospho ulk1 ser317 - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc anti phosphorylated ulk1 ser757
KEY RESOURCES TABLE
Anti Phosphorylated Ulk1 Ser757, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ulk1/Phospho-ULK1+(Ser757)+Antibody/pmc12823391-280-99-104
Average 96 stars, based on 1 article reviews
anti phosphorylated ulk1 ser757 - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc anti phosphorylated ulk1 ser555 d1h4
KEY RESOURCES TABLE
Anti Phosphorylated Ulk1 Ser555 D1h4, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ulk1/Phospho-ULK1+(Ser555)+Rabbit+mAb/pmc12823391-280-106-112
Average 96 stars, based on 1 article reviews
anti phosphorylated ulk1 ser555 d1h4 - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

94
Cell Signaling Technology Inc rabbit anti phospho ulk1 ser638
KEY RESOURCES TABLE
Rabbit Anti Phospho Ulk1 Ser638, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ulk1/Phospho-ULK1+(Ser638)+Rabbit+mAb/ppr0641963-65-52-57
Average 94 stars, based on 1 article reviews
rabbit anti phospho ulk1 ser638 - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

Image Search Results


( A ) Schematic illustration of the inducible and conditional Ulk1 knockout mouse MPN model used, and analyses performed. (BMT – bone marrow transplant) ( B ) Hemoglobin (Hb) levels, ( C ) hematocrit (HCT) percentage and ( D ) red blood cell (RBC) counts in peripheral blood of Ulk1 +/+ Jak2 V617F and Ulk1 FL/FL Jak2 V617F recipient mice are shown for pre- (day 21) and post- (day 42) pIpC injection. ( E ) Spleen weight and ( F ) percentage of GFP + splenocytes three weeks post pIpC injection of the recipient mice. ( G ) Percentage of GFP + ( G-i ) Ter119 med CD71 high proerythroblasts (R1), ( G-ii ) Ter119 high CD71 high basophilic erythroblasts (R2), and ( G-iii ) Ter119 high CD71 med late basophilic and polychromatophilic erythroblasts (R3) and Ter119 high CD71 low orthochromatophilic erythroblasts (R4) in the spleen of recipient mice three weeks post pIpC injection. ( H ) Percentage of GFP + bone marrow (BM) cells three weeks post pIpC injection of the recipient mice. Percentage of GFP + ( I-i ) R1, ( I-ii ) R2, and ( I-iii ) R3+R4 cells in the BM of recipient mice three weeks post pIpC injection. ( B-I ) Box plots show distribution of data from 6 mice per group. ( B-D ) Mixed effects models were used to analyze these data, with Hb, HCT or RBC counts as the outcome variable, and time (pre- and post-pIpC), genotype and their interaction as fixed effects, and a mouse random effect to account for within-mouse correlation between repeated measurements. Fisher’s LSD approach was used, and pairwise comparison p -values were not adjusted. ( E-I ) Statistical analyses were performed using Mann-Whitney test. ( B-I ) Statistically significant p -values are reported. ns - not significant. See also supplemental figures 1 – 3 .

Journal: Molecular and cellular biology

Article Title: Loss of function mouse models reveal a novel regulatory function for ULK1 in myeloproliferative neoplasms

doi: 10.1080/10985549.2025.2529837

Figure Lengend Snippet: ( A ) Schematic illustration of the inducible and conditional Ulk1 knockout mouse MPN model used, and analyses performed. (BMT – bone marrow transplant) ( B ) Hemoglobin (Hb) levels, ( C ) hematocrit (HCT) percentage and ( D ) red blood cell (RBC) counts in peripheral blood of Ulk1 +/+ Jak2 V617F and Ulk1 FL/FL Jak2 V617F recipient mice are shown for pre- (day 21) and post- (day 42) pIpC injection. ( E ) Spleen weight and ( F ) percentage of GFP + splenocytes three weeks post pIpC injection of the recipient mice. ( G ) Percentage of GFP + ( G-i ) Ter119 med CD71 high proerythroblasts (R1), ( G-ii ) Ter119 high CD71 high basophilic erythroblasts (R2), and ( G-iii ) Ter119 high CD71 med late basophilic and polychromatophilic erythroblasts (R3) and Ter119 high CD71 low orthochromatophilic erythroblasts (R4) in the spleen of recipient mice three weeks post pIpC injection. ( H ) Percentage of GFP + bone marrow (BM) cells three weeks post pIpC injection of the recipient mice. Percentage of GFP + ( I-i ) R1, ( I-ii ) R2, and ( I-iii ) R3+R4 cells in the BM of recipient mice three weeks post pIpC injection. ( B-I ) Box plots show distribution of data from 6 mice per group. ( B-D ) Mixed effects models were used to analyze these data, with Hb, HCT or RBC counts as the outcome variable, and time (pre- and post-pIpC), genotype and their interaction as fixed effects, and a mouse random effect to account for within-mouse correlation between repeated measurements. Fisher’s LSD approach was used, and pairwise comparison p -values were not adjusted. ( E-I ) Statistical analyses were performed using Mann-Whitney test. ( B-I ) Statistically significant p -values are reported. ns - not significant. See also supplemental figures 1 – 3 .

Article Snippet: Breeding pairs were set using both male and female mice (6–12-week-old) between: 1) Ulk1 +/+ mice (C57BL/6J, The Jackson Laboratory, Strain #:000664, RRID:IMSR_JAX:000664) and MxCre + mice (B6.Cg-Tg(Mx1-cre)1Cgn/J, The Jackson Laboratory, Strain #:003556, RRID:IMSR_JAX:003556) to generate Ulk1 +/+ MxCre + donor mice, 2) Ulk1 FL/FL mice (B6.129- Ulk1 tm1Thsn /J, The Jackson Laboratory, Strain #:017976, RRID:IMSR_JAX:017976) 22 and MxCre + mice to generate Ulk1 FL/+ MxCre + that were used for breeding to then generate Ulk1 FL/FL MxCre + donor mice, and 3) Jak2 V617F/+ conditional knock-in (KI) mice 27 (kindly provided by B. L. Ebert and A. Mullally, Harvard Medical School) and VavCre + mice (B6.Cg- Commd10 Tg(Vav1-icre)A2Kio /J, The Jackson Laboratory, Strain #: 008610, RRID:IMSR_JAX:008610) to generate Jak2 V617F/+ VavCre + donor mice.

Techniques: In Vivo, Knock-Out, Injection, Comparison, MANN-WHITNEY

( A ) Schematic illustration of the Ulk1 wild type versus Ulk1 knockout mouse MPN model used, and analyses performed. ( B ) Percentage of engraftment of CD45.2+ cells, ( C ) hemoglobin (Hb) levels, ( D ) hematocrit (HCT) percentage and ( E ) red blood cell (RBC) counts in peripheral blood of recipient mice are shown for two- and four-weeks post bone marrow transplant (BMT). ( F ) Percentage of GFP + BM cells four weeks post BMT of the recipient mice. ( G ) Percentage of GFP + ( G-i ) Ter119 med CD71 high proerythroblasts (R1), ( G-ii ) Pre-CFU-E, and ( G-iii ) PreMegE in the BM of recipient mice four weeks post BMT. ( H ) Spleen weight and ( I ) percentage of GFP + splenocytes four weeks post BMT of the recipient mice. ( J ) Percentage of GFP + ( J-i ) R1, ( J-ii ) R2 and ( J-iii ) R3+R4 cells in the spleen of recipient mice four weeks post BMT. ( B-E ) Data shown are means ± SD (n = 10 per group). Mixed effects models were used to analyze these data, with engraftment, Hb, HCT or RBC counts as the outcome variable, and time post-bone marrow transplant (BMT) (2 and 4 weeks), genotype and their interaction as fixed effects, and a mouse random effect to account for within-mouse correlation between repeated measurements. Fisher’s LSD approach was used, and pairwise comparison p -values were not adjusted. ( F-J ) Box plots show distribution of data from 10 mice per group. Statistical analyses were performed using Mann-Whitney test. ( B-J ) Statistically significant p -values are reported. See also supplemental figures 4 and 5 .

Journal: Molecular and cellular biology

Article Title: Loss of function mouse models reveal a novel regulatory function for ULK1 in myeloproliferative neoplasms

doi: 10.1080/10985549.2025.2529837

Figure Lengend Snippet: ( A ) Schematic illustration of the Ulk1 wild type versus Ulk1 knockout mouse MPN model used, and analyses performed. ( B ) Percentage of engraftment of CD45.2+ cells, ( C ) hemoglobin (Hb) levels, ( D ) hematocrit (HCT) percentage and ( E ) red blood cell (RBC) counts in peripheral blood of recipient mice are shown for two- and four-weeks post bone marrow transplant (BMT). ( F ) Percentage of GFP + BM cells four weeks post BMT of the recipient mice. ( G ) Percentage of GFP + ( G-i ) Ter119 med CD71 high proerythroblasts (R1), ( G-ii ) Pre-CFU-E, and ( G-iii ) PreMegE in the BM of recipient mice four weeks post BMT. ( H ) Spleen weight and ( I ) percentage of GFP + splenocytes four weeks post BMT of the recipient mice. ( J ) Percentage of GFP + ( J-i ) R1, ( J-ii ) R2 and ( J-iii ) R3+R4 cells in the spleen of recipient mice four weeks post BMT. ( B-E ) Data shown are means ± SD (n = 10 per group). Mixed effects models were used to analyze these data, with engraftment, Hb, HCT or RBC counts as the outcome variable, and time post-bone marrow transplant (BMT) (2 and 4 weeks), genotype and their interaction as fixed effects, and a mouse random effect to account for within-mouse correlation between repeated measurements. Fisher’s LSD approach was used, and pairwise comparison p -values were not adjusted. ( F-J ) Box plots show distribution of data from 10 mice per group. Statistical analyses were performed using Mann-Whitney test. ( B-J ) Statistically significant p -values are reported. See also supplemental figures 4 and 5 .

Article Snippet: Breeding pairs were set using both male and female mice (6–12-week-old) between: 1) Ulk1 +/+ mice (C57BL/6J, The Jackson Laboratory, Strain #:000664, RRID:IMSR_JAX:000664) and MxCre + mice (B6.Cg-Tg(Mx1-cre)1Cgn/J, The Jackson Laboratory, Strain #:003556, RRID:IMSR_JAX:003556) to generate Ulk1 +/+ MxCre + donor mice, 2) Ulk1 FL/FL mice (B6.129- Ulk1 tm1Thsn /J, The Jackson Laboratory, Strain #:017976, RRID:IMSR_JAX:017976) 22 and MxCre + mice to generate Ulk1 FL/+ MxCre + that were used for breeding to then generate Ulk1 FL/FL MxCre + donor mice, and 3) Jak2 V617F/+ conditional knock-in (KI) mice 27 (kindly provided by B. L. Ebert and A. Mullally, Harvard Medical School) and VavCre + mice (B6.Cg- Commd10 Tg(Vav1-icre)A2Kio /J, The Jackson Laboratory, Strain #: 008610, RRID:IMSR_JAX:008610) to generate Jak2 V617F/+ VavCre + donor mice.

Techniques: In Vivo, Knock-Out, Comparison, MANN-WHITNEY

( A ) Schematic illustration of the Jak2 V617F knock-in MPN transplant mouse model used, treatment regimen, and analyses performed. ( B ) Hemoglobin (Hb) levels, ( C ) hematocrit (HCT) percentage and ( D ) red blood cell (RBC) counts in peripheral blood of recipient mice are shown for each treatment group four weeks post treatment initiation. ( E ) Percentage of Ter119 med CD71 high proerythroblasts (R1), ( F ) Ter119 high CD71 high basophilic erythroblasts (R2) and ( G ) Ter119 high CD71 med late basophilic and polychromatophilic erythroblasts (R3) and Ter119 high CD71 low orthochromatophilic erythroblasts (R4) in the BM of recipient mice four weeks post treatment initiation. ( H ) Spleen weight and percentage of ( I ) R1, ( J ) R2 and ( K ) R3+R4 cells in the spleen of recipient mice four weeks post treatment initiation. ( B-K ) Box plots show distribution of data from 10 mice per group. Statistical analyses were performed using Mann-Whitney test. Statistically significant p -values are reported. See also supplemental figures 6 and 7 . ( L-M ) Cellular viability of JAK2 V617F -positive ( L ) HEL and ( M ) SET-2 cells treated with either DMSO-vehicle control (Ctrl) or with increasing doses of the ULK1 inhibitor SBP-7455 for five days, as indicated, was measured using WST-1 cell viability reagent. Data are expressed as percent cell viability relative to Ctrl-treated cells and represent means ± SEM of ( L ) four and ( M ) three independent experiments. IC50 values are shown. ( N ) Clonogenic capability of HEL cells treated with either vehicle-control (DMSO) or with increasing doses of the ULK1 inhibitor SBP-7455, as indicated. Data are expressed as percent colony formation relative to DMSO-treated cells (control) and represent means ± SEM of three independent experiments. Statistical analysis was performed using Welch’s ANOVA test that accounts for unequal variances followed by Dunnett’s T3 pairwise multiple comparisons test. Statistically significant p -values are reported. Test for linear trend based on the one-way ANOVA model showed a significant decrease in colony formation with increased dose of ULK1 inhibitor ( p <0.0001). See also supplemental figure 8 .

Journal: Molecular and cellular biology

Article Title: Loss of function mouse models reveal a novel regulatory function for ULK1 in myeloproliferative neoplasms

doi: 10.1080/10985549.2025.2529837

Figure Lengend Snippet: ( A ) Schematic illustration of the Jak2 V617F knock-in MPN transplant mouse model used, treatment regimen, and analyses performed. ( B ) Hemoglobin (Hb) levels, ( C ) hematocrit (HCT) percentage and ( D ) red blood cell (RBC) counts in peripheral blood of recipient mice are shown for each treatment group four weeks post treatment initiation. ( E ) Percentage of Ter119 med CD71 high proerythroblasts (R1), ( F ) Ter119 high CD71 high basophilic erythroblasts (R2) and ( G ) Ter119 high CD71 med late basophilic and polychromatophilic erythroblasts (R3) and Ter119 high CD71 low orthochromatophilic erythroblasts (R4) in the BM of recipient mice four weeks post treatment initiation. ( H ) Spleen weight and percentage of ( I ) R1, ( J ) R2 and ( K ) R3+R4 cells in the spleen of recipient mice four weeks post treatment initiation. ( B-K ) Box plots show distribution of data from 10 mice per group. Statistical analyses were performed using Mann-Whitney test. Statistically significant p -values are reported. See also supplemental figures 6 and 7 . ( L-M ) Cellular viability of JAK2 V617F -positive ( L ) HEL and ( M ) SET-2 cells treated with either DMSO-vehicle control (Ctrl) or with increasing doses of the ULK1 inhibitor SBP-7455 for five days, as indicated, was measured using WST-1 cell viability reagent. Data are expressed as percent cell viability relative to Ctrl-treated cells and represent means ± SEM of ( L ) four and ( M ) three independent experiments. IC50 values are shown. ( N ) Clonogenic capability of HEL cells treated with either vehicle-control (DMSO) or with increasing doses of the ULK1 inhibitor SBP-7455, as indicated. Data are expressed as percent colony formation relative to DMSO-treated cells (control) and represent means ± SEM of three independent experiments. Statistical analysis was performed using Welch’s ANOVA test that accounts for unequal variances followed by Dunnett’s T3 pairwise multiple comparisons test. Statistically significant p -values are reported. Test for linear trend based on the one-way ANOVA model showed a significant decrease in colony formation with increased dose of ULK1 inhibitor ( p <0.0001). See also supplemental figure 8 .

Article Snippet: Breeding pairs were set using both male and female mice (6–12-week-old) between: 1) Ulk1 +/+ mice (C57BL/6J, The Jackson Laboratory, Strain #:000664, RRID:IMSR_JAX:000664) and MxCre + mice (B6.Cg-Tg(Mx1-cre)1Cgn/J, The Jackson Laboratory, Strain #:003556, RRID:IMSR_JAX:003556) to generate Ulk1 +/+ MxCre + donor mice, 2) Ulk1 FL/FL mice (B6.129- Ulk1 tm1Thsn /J, The Jackson Laboratory, Strain #:017976, RRID:IMSR_JAX:017976) 22 and MxCre + mice to generate Ulk1 FL/+ MxCre + that were used for breeding to then generate Ulk1 FL/FL MxCre + donor mice, and 3) Jak2 V617F/+ conditional knock-in (KI) mice 27 (kindly provided by B. L. Ebert and A. Mullally, Harvard Medical School) and VavCre + mice (B6.Cg- Commd10 Tg(Vav1-icre)A2Kio /J, The Jackson Laboratory, Strain #: 008610, RRID:IMSR_JAX:008610) to generate Jak2 V617F/+ VavCre + donor mice.

Techniques: Inhibition, Activity Assay, In Vivo, Knock-In, MANN-WHITNEY, Control

( A-B ) Immunoblotting analysis of the indicated proteins in lysates from non-targeting (NT) control, Atg7 KO and Ulk1 KO Jak2 V617F -positive Ba/F3-EpoR + GFP-LC3-RFP-expressing cells. ( C ) Percentage of autophagy measured as percentage of GFP negative cells assessed by flow cytometry analyses of NT control, Atg7 KO and Ulk1 KO Jak2 V617F -positive Ba/F3-EpoR + GFP-LC3-RFP-expressing cells cultured under normal nutrient conditions (RPMI 1640 media supplemented with 10% FBS and 10 ng/mL of IL-3, no starvation) or under starvation conditions (RPMI 1640 media without serum and IL-3) for 48 hours. Scatter dot plot shows means ± SD. Statistical analysis was performed using Welch’s ANOVA test that accounts for unequal variances followed by Dunnett’s T3 pairwise multiple comparisons test. Statistically significant p -values are reported. ( D-F ) Immunoblotting analysis of the indicated proteins in lysates from ( D ) Cas9-control compared to ULK1 KO HEL cells and from ( E ) HEL cells treated with either DMSO-vehicle control (C), 5μM SBP-7455 (S), 100nM bafilomycin A1 (B) or with the combination of SBP-7455 and bafilomycin A1 (S+B) for 4 hours under either nutrient-starvation conditions (HBSS) or normal complete nutrient-conditions (RPMI). Immunoblots shown are representative of three independent experiments. ( F ) SET-2 cells treated with either DMSO-vehicle control (C), 5μM SBP-7455 (S), 100nM bafilomycin A1 (B) or with the combination of SBP-7455 and bafilomycin A1 (S+B) for 4 hours under either nutrient-starvation conditions (HBSS) or normal complete nutrient-conditions (RPMI). Immunoblots shown are representative of three independent experiments.

Journal: Molecular and cellular biology

Article Title: Loss of function mouse models reveal a novel regulatory function for ULK1 in myeloproliferative neoplasms

doi: 10.1080/10985549.2025.2529837

Figure Lengend Snippet: ( A-B ) Immunoblotting analysis of the indicated proteins in lysates from non-targeting (NT) control, Atg7 KO and Ulk1 KO Jak2 V617F -positive Ba/F3-EpoR + GFP-LC3-RFP-expressing cells. ( C ) Percentage of autophagy measured as percentage of GFP negative cells assessed by flow cytometry analyses of NT control, Atg7 KO and Ulk1 KO Jak2 V617F -positive Ba/F3-EpoR + GFP-LC3-RFP-expressing cells cultured under normal nutrient conditions (RPMI 1640 media supplemented with 10% FBS and 10 ng/mL of IL-3, no starvation) or under starvation conditions (RPMI 1640 media without serum and IL-3) for 48 hours. Scatter dot plot shows means ± SD. Statistical analysis was performed using Welch’s ANOVA test that accounts for unequal variances followed by Dunnett’s T3 pairwise multiple comparisons test. Statistically significant p -values are reported. ( D-F ) Immunoblotting analysis of the indicated proteins in lysates from ( D ) Cas9-control compared to ULK1 KO HEL cells and from ( E ) HEL cells treated with either DMSO-vehicle control (C), 5μM SBP-7455 (S), 100nM bafilomycin A1 (B) or with the combination of SBP-7455 and bafilomycin A1 (S+B) for 4 hours under either nutrient-starvation conditions (HBSS) or normal complete nutrient-conditions (RPMI). Immunoblots shown are representative of three independent experiments. ( F ) SET-2 cells treated with either DMSO-vehicle control (C), 5μM SBP-7455 (S), 100nM bafilomycin A1 (B) or with the combination of SBP-7455 and bafilomycin A1 (S+B) for 4 hours under either nutrient-starvation conditions (HBSS) or normal complete nutrient-conditions (RPMI). Immunoblots shown are representative of three independent experiments.

Article Snippet: Breeding pairs were set using both male and female mice (6–12-week-old) between: 1) Ulk1 +/+ mice (C57BL/6J, The Jackson Laboratory, Strain #:000664, RRID:IMSR_JAX:000664) and MxCre + mice (B6.Cg-Tg(Mx1-cre)1Cgn/J, The Jackson Laboratory, Strain #:003556, RRID:IMSR_JAX:003556) to generate Ulk1 +/+ MxCre + donor mice, 2) Ulk1 FL/FL mice (B6.129- Ulk1 tm1Thsn /J, The Jackson Laboratory, Strain #:017976, RRID:IMSR_JAX:017976) 22 and MxCre + mice to generate Ulk1 FL/+ MxCre + that were used for breeding to then generate Ulk1 FL/FL MxCre + donor mice, and 3) Jak2 V617F/+ conditional knock-in (KI) mice 27 (kindly provided by B. L. Ebert and A. Mullally, Harvard Medical School) and VavCre + mice (B6.Cg- Commd10 Tg(Vav1-icre)A2Kio /J, The Jackson Laboratory, Strain #: 008610, RRID:IMSR_JAX:008610) to generate Jak2 V617F/+ VavCre + donor mice.

Techniques: Inhibition, Western Blot, Control, Expressing, Flow Cytometry, Cell Culture

( A-B ) HEL cells were treated with either vehicle (DMSO, Ctrl), 5μM SBI-0206965 (SBI) or 5μM ULK101 for 6 hours followed by RNA-seq and analysis of transcript expression. ( A ) Heatmap of differentially expressed genes between treatment groups (adj. p val. < 0.01). ( B ) MA plot of genes significantly changed by drug-targeted inhibition of ULK1 in HEL cells versus control (adj. p val. < 0.01). In purple are represented up-regulated genes and in green are represented down-regulated genes. ( C and D ) Enriched ontology clusters for genes that are ( C ) increased or ( D ) decreased after drug-targeted inhibition of ULK1 in HEL cells. ( A-D ) Data are from 4 biological replicates per condition. See also supplemental figures 9 – 11 .

Journal: Molecular and cellular biology

Article Title: Loss of function mouse models reveal a novel regulatory function for ULK1 in myeloproliferative neoplasms

doi: 10.1080/10985549.2025.2529837

Figure Lengend Snippet: ( A-B ) HEL cells were treated with either vehicle (DMSO, Ctrl), 5μM SBI-0206965 (SBI) or 5μM ULK101 for 6 hours followed by RNA-seq and analysis of transcript expression. ( A ) Heatmap of differentially expressed genes between treatment groups (adj. p val. < 0.01). ( B ) MA plot of genes significantly changed by drug-targeted inhibition of ULK1 in HEL cells versus control (adj. p val. < 0.01). In purple are represented up-regulated genes and in green are represented down-regulated genes. ( C and D ) Enriched ontology clusters for genes that are ( C ) increased or ( D ) decreased after drug-targeted inhibition of ULK1 in HEL cells. ( A-D ) Data are from 4 biological replicates per condition. See also supplemental figures 9 – 11 .

Article Snippet: Breeding pairs were set using both male and female mice (6–12-week-old) between: 1) Ulk1 +/+ mice (C57BL/6J, The Jackson Laboratory, Strain #:000664, RRID:IMSR_JAX:000664) and MxCre + mice (B6.Cg-Tg(Mx1-cre)1Cgn/J, The Jackson Laboratory, Strain #:003556, RRID:IMSR_JAX:003556) to generate Ulk1 +/+ MxCre + donor mice, 2) Ulk1 FL/FL mice (B6.129- Ulk1 tm1Thsn /J, The Jackson Laboratory, Strain #:017976, RRID:IMSR_JAX:017976) 22 and MxCre + mice to generate Ulk1 FL/+ MxCre + that were used for breeding to then generate Ulk1 FL/FL MxCre + donor mice, and 3) Jak2 V617F/+ conditional knock-in (KI) mice 27 (kindly provided by B. L. Ebert and A. Mullally, Harvard Medical School) and VavCre + mice (B6.Cg- Commd10 Tg(Vav1-icre)A2Kio /J, The Jackson Laboratory, Strain #: 008610, RRID:IMSR_JAX:008610) to generate Jak2 V617F/+ VavCre + donor mice.

Techniques: Inhibition, Activity Assay, Gene Expression, RNA Sequencing, Expressing, Control

( A-E ) Scatter dot plots of PIM1 , ID2 , HES1 , CTR9 and PDCD2 expression in healthy individuals (normal, n = 11) and patients with ET (n = 47), PV (n = 28) and MF (n = 18). Data extracted from GSE5464672. Shown are means ± SEM of Log2 mRNA expression. Statistical analyses were performed using one-way ANOVA followed by Dunnett’s multiple comparisons adjustment comparing each MPN group vs. Normal group. Statistically significant p -values are reported. ( F-J ) mRNA expression of the indicated genes was assessed by qRT-PCR analysis for HEL cells treated for 6 hours with either vehicle (DMSO, Control) or SBP-7455 (SBP), as indicated. Data are means ± SEM from three independent experiments. Fold changes relative to control (dashed line) were calculated for each experimental replicate (SBP/DSMO), and fold changes were compared to FC=1 using a one-sample t-test, p values are reported. See also supplemental figure 12 .

Journal: Molecular and cellular biology

Article Title: Loss of function mouse models reveal a novel regulatory function for ULK1 in myeloproliferative neoplasms

doi: 10.1080/10985549.2025.2529837

Figure Lengend Snippet: ( A-E ) Scatter dot plots of PIM1 , ID2 , HES1 , CTR9 and PDCD2 expression in healthy individuals (normal, n = 11) and patients with ET (n = 47), PV (n = 28) and MF (n = 18). Data extracted from GSE5464672. Shown are means ± SEM of Log2 mRNA expression. Statistical analyses were performed using one-way ANOVA followed by Dunnett’s multiple comparisons adjustment comparing each MPN group vs. Normal group. Statistically significant p -values are reported. ( F-J ) mRNA expression of the indicated genes was assessed by qRT-PCR analysis for HEL cells treated for 6 hours with either vehicle (DMSO, Control) or SBP-7455 (SBP), as indicated. Data are means ± SEM from three independent experiments. Fold changes relative to control (dashed line) were calculated for each experimental replicate (SBP/DSMO), and fold changes were compared to FC=1 using a one-sample t-test, p values are reported. See also supplemental figure 12 .

Article Snippet: Breeding pairs were set using both male and female mice (6–12-week-old) between: 1) Ulk1 +/+ mice (C57BL/6J, The Jackson Laboratory, Strain #:000664, RRID:IMSR_JAX:000664) and MxCre + mice (B6.Cg-Tg(Mx1-cre)1Cgn/J, The Jackson Laboratory, Strain #:003556, RRID:IMSR_JAX:003556) to generate Ulk1 +/+ MxCre + donor mice, 2) Ulk1 FL/FL mice (B6.129- Ulk1 tm1Thsn /J, The Jackson Laboratory, Strain #:017976, RRID:IMSR_JAX:017976) 22 and MxCre + mice to generate Ulk1 FL/+ MxCre + that were used for breeding to then generate Ulk1 FL/FL MxCre + donor mice, and 3) Jak2 V617F/+ conditional knock-in (KI) mice 27 (kindly provided by B. L. Ebert and A. Mullally, Harvard Medical School) and VavCre + mice (B6.Cg- Commd10 Tg(Vav1-icre)A2Kio /J, The Jackson Laboratory, Strain #: 008610, RRID:IMSR_JAX:008610) to generate Jak2 V617F/+ VavCre + donor mice.

Techniques: Inhibition, Expressing, Quantitative RT-PCR, Control

( A-E ) qRT-PCR analysis of the indicated genes mRNA expression in murine c-kit + bone marrow Jak2 V617F/+ VavCre + cells from 3 mice treated for 6 hours with either vehicle (DMSO, Control) or 5μM SBP-7455 (SBP), as indicated. Data are means ± SD across three different mice. Fold changes were calculated relative to gene expression from one randomly selected vehicle control-treated mouse sample. Statistical analyses were performed using two-tailed unpaired t test with Welch’s correction. Statistically significant p -values are reported. ( F-J ) qRT-PCR analysis of the indicated genes mRNA expression in Cas9-control and ULK1 KO HEL cells, as indicated. Data are means ± SD across three independent experiments. Fold changes were calculated relative to gene expression from one randomly selected Cas9 control sample. Statistical analyses were performed using two-tailed unpaired t test with Welch’s correction. Statistically significant p -values are reported. See also supplemental figures 13 – 15 .

Journal: Molecular and cellular biology

Article Title: Loss of function mouse models reveal a novel regulatory function for ULK1 in myeloproliferative neoplasms

doi: 10.1080/10985549.2025.2529837

Figure Lengend Snippet: ( A-E ) qRT-PCR analysis of the indicated genes mRNA expression in murine c-kit + bone marrow Jak2 V617F/+ VavCre + cells from 3 mice treated for 6 hours with either vehicle (DMSO, Control) or 5μM SBP-7455 (SBP), as indicated. Data are means ± SD across three different mice. Fold changes were calculated relative to gene expression from one randomly selected vehicle control-treated mouse sample. Statistical analyses were performed using two-tailed unpaired t test with Welch’s correction. Statistically significant p -values are reported. ( F-J ) qRT-PCR analysis of the indicated genes mRNA expression in Cas9-control and ULK1 KO HEL cells, as indicated. Data are means ± SD across three independent experiments. Fold changes were calculated relative to gene expression from one randomly selected Cas9 control sample. Statistical analyses were performed using two-tailed unpaired t test with Welch’s correction. Statistically significant p -values are reported. See also supplemental figures 13 – 15 .

Article Snippet: Breeding pairs were set using both male and female mice (6–12-week-old) between: 1) Ulk1 +/+ mice (C57BL/6J, The Jackson Laboratory, Strain #:000664, RRID:IMSR_JAX:000664) and MxCre + mice (B6.Cg-Tg(Mx1-cre)1Cgn/J, The Jackson Laboratory, Strain #:003556, RRID:IMSR_JAX:003556) to generate Ulk1 +/+ MxCre + donor mice, 2) Ulk1 FL/FL mice (B6.129- Ulk1 tm1Thsn /J, The Jackson Laboratory, Strain #:017976, RRID:IMSR_JAX:017976) 22 and MxCre + mice to generate Ulk1 FL/+ MxCre + that were used for breeding to then generate Ulk1 FL/FL MxCre + donor mice, and 3) Jak2 V617F/+ conditional knock-in (KI) mice 27 (kindly provided by B. L. Ebert and A. Mullally, Harvard Medical School) and VavCre + mice (B6.Cg- Commd10 Tg(Vav1-icre)A2Kio /J, The Jackson Laboratory, Strain #: 008610, RRID:IMSR_JAX:008610) to generate Jak2 V617F/+ VavCre + donor mice.

Techniques: Inhibition, Quantitative RT-PCR, Expressing, Control, Gene Expression, Two Tailed Test

(A) Cross-sections of quadriceps from control (Ulk1+/−Ulk2−/flox) and Ulk1/2 hypomorph (Ulk1−/− Ulk2−/flox) mice at 24 weeks were stained with H&E and modified Gomori trichrome staining. Arrow indicates a crescentic inclusion and arrowhead indicates a vacuole. Scale bars, 25 μm.

Journal: Molecular cell

Article Title: ULK1/2 Regulates Stress Granule Disassembly Through Phosphorylation and Activation of VCP/p97

doi: 10.1016/j.molcel.2019.03.027

Figure Lengend Snippet: (A) Cross-sections of quadriceps from control (Ulk1+/−Ulk2−/flox) and Ulk1/2 hypomorph (Ulk1−/− Ulk2−/flox) mice at 24 weeks were stained with H&E and modified Gomori trichrome staining. Arrow indicates a crescentic inclusion and arrowhead indicates a vacuole. Scale bars, 25 μm.

Article Snippet: The pMXs-IP-EGFP-ULK1 (38193) and pMXs-IP-EGFP-ULK2 (38201) were obtained from Addgene.

Techniques: Staining, Modification

(A) HEK293T cells were transfected with ULK1-DDK or ULK2-DDK and subjected to heat shock at 43°C for 1 h. Immediately following heat shock, cells were lysed and immunoprecipitated for DDK, followed by immunoblot against the indicated proteins.

Journal: Molecular cell

Article Title: ULK1/2 Regulates Stress Granule Disassembly Through Phosphorylation and Activation of VCP/p97

doi: 10.1016/j.molcel.2019.03.027

Figure Lengend Snippet: (A) HEK293T cells were transfected with ULK1-DDK or ULK2-DDK and subjected to heat shock at 43°C for 1 h. Immediately following heat shock, cells were lysed and immunoprecipitated for DDK, followed by immunoblot against the indicated proteins.

Article Snippet: The pMXs-IP-EGFP-ULK1 (38193) and pMXs-IP-EGFP-ULK2 (38201) were obtained from Addgene.

Techniques: Transfection, Immunoprecipitation, Western Blot

KEY RESOURCES TABLE

Journal: Molecular cell

Article Title: ULK1/2 Regulates Stress Granule Disassembly Through Phosphorylation and Activation of VCP/p97

doi: 10.1016/j.molcel.2019.03.027

Figure Lengend Snippet: KEY RESOURCES TABLE

Article Snippet: The pMXs-IP-EGFP-ULK1 (38193) and pMXs-IP-EGFP-ULK2 (38201) were obtained from Addgene.

Techniques: Recombinant, Western Blot, Software

KEY RESOURCES TABLE

Journal: Cell reports

Article Title: Selenium Deficiency Is Associated with Pro-longevity Mechanisms

doi: 10.1016/j.celrep.2019.05.001

Figure Lengend Snippet: KEY RESOURCES TABLE

Article Snippet: anti-p-ULK1 , Cell Signaling Technology, sampler kit (8359T) , Ser 555 (mAb 5869) Ser 757 (mAb 6888).

Techniques: Recombinant, Expressing, Purification, Sequencing, Software